Brief: Cassava Sciences Q1 Basic EPS USD 0.58

Filana Therapeutics

10/05/2024 21:02

May 10 (Reuters) - Cassava Sciences Q1 operating income USD -19.934 million.
* Q1 net income USD 25.043 million
* Q1 operating expenses USD 19.934 million